Status:
COMPLETED
Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System
Lead Sponsor:
Per Borghammer
Collaborating Sponsors:
Lundbeck Foundation
Conditions:
Parkinson's Disease
Eligibility:
MALE
45-75 years
Brief Summary
AIM: To validate the tracer \[11C\]donepezil for use in the parasympathetic nervous system. MATERIALS AND METHODS: The Investigators will include 7 healthy males aged 45-75 in our study. The particip...
Detailed Description
Please see the published paper wherein all details are listed: In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic ...
Eligibility Criteria
Inclusion
- male
- 45-75 years
Exclusion
- dementia,
- psychiatric diseases,
- serious medical illness including any type of previous cancer, any drug with known interaction with the autonomic nervous system
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT01877538
Start Date
May 1 2013
End Date
July 1 2013
Last Update
March 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Nuclear Medicine and PET centre, Aarhus University Hospital
Aarhus, Denmark, 8000